Telomerase-pulsed dendritic cells: preclinical results and outcome of a clinical phase I/II trial in patients with metastatic renal cell carcinoma

Objective: Therapeutic vaccination with dendritic cells (DC) showed promising results in first clinical trials in cases of metastatic renal cell carcinoma (RCC). Human telomerase reverse transcriptase (hTERT) could be a potential target because it is detectable in more than 85% of human tumors inclu...

Descripción completa

Detalles Bibliográficos
Autores principales: Märten, Angela, Sievers, Elisabeth, Albers, Peter, Müller, Stefan, Franchy, Christian, von Ruecker, Alexander, Strunk, Holger, Schild, Hans Heinz, Schmiedel, Alexandra, Sommer, Thorsten, Sauerbruch, Tilman, Schmidt-Wolf, Ingo G.H.
Formato: Texto
Lenguaje:English
Publicado: German Medical Science 2006
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2703216/
https://www.ncbi.nlm.nih.gov/pubmed/19675693

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2703216/
https://www.ncbi.nlm.nih.gov/pubmed/19675693

Ejemplares similares